Registration and Reimbursement of New Cancer Medicines in Australia—Response to Letter to the Editor by Michael Wonder

Abstract

Authors

Richard Macaulay

Full Text Cite This Article

Explore Related HEOR by Topic

Back to Volume 9 - Focus on Asia
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×